Seizure Disorders

Latest News

Impact of Published Data on Pediatric Status Epilepticus Treatment Delay

Published evidence of delays in treatment for pediatric rSE was not associated with improvement in time to treatment but with an increase in those who received BZD.

New Treatment Option for Dravet Syndrome Approved

The FDA has approved Fintepla® (fenfluramine; Zogenix) oral solution for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.

Hallucinations Tied to Mental Illness in Individuals With Seizures

Hallucinatory experiences are also strong risk markers for suicidal behavior in those with seizures.

Recommendations for Optimizing Epilepsy Care During the COVID-19 Pandemic

Consensus recommendations are provided to optimize the care of people with epilepsy.

Telemedicine Checklist for Epileptologists During COVID-19

Naoto Kuroda, MD, of Wayne State University, in Detroit, Michigan, provided a checklist for clinicians about what they should ask and look out for in a telemedicine session with patients with epilepsy.

Cognitive Behavioral Therapy No Better Than Standard Care For Dissociative Seizures

Dissociative seizures are paroxysmal episodes distinctive from epileptic seizures or syncope, and patients with dissociative seizures often have comorbid psychiatric difficulties.

Unapproved Cannabidiol, Curcumin Injectables Marketed for Multiple Disorders Recalled

Biota Biosciences announced the voluntary recall of CBD Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables due to the products being marketed without the approval of the FDA.

Clinicians Call for Optimization of Status Epilepticus ICU Care During COVID-19 Era

During COVID-19, clinicians will be challenged by a lack of ICU resources and ventilators to manage patients with status epilepticus.

Epilepsy and COVID-19: Connection and Considerations

A brief communication provides information about the associations between, and the considerations for, COVID-19 and epilepsy.

STOPBAG2 Offers High Discriminatory Power for Predicting OSA Severity in Adults With Epilepsy

The STOPBAG2 scoring instrument, which incorporates sleep-related symptoms and continuous variables for age and BMI, offers greater discriminatory power for predicting all levels of OSA severity in adults with epilepsy.